Overview
EchoGo AI platform analyzing standard echocardiograms to detect HFpEF, cardiac amyloidosis, and related cardiovascular conditions with FDA-cleared, Medicare-reimbursed probability scoring integrated into clinical workflows.
Product and company
Ultromics — Medical Imaging is a verified product offering linked to the Brel Digital company profile for Ultromics.
Use cases
EchoGo AI platform analyzing standard echocardiograms to detect HFpEF, cardiac amyloidosis, and related cardiovascular conditions with FDA-cleared, Medicare-reimbursed probability scoring integrated into clinical workflows.
Target customer
Cardiology departments, echo labs, health systems including UChicago Medicine and Mayo Clinic partners, and NHS cardiovascular pathways seeking AI-enhanced echo interpretation.
Technologies
Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging, Predictive Analytics.
Sources and references
- Official product / company source: https://www.ultromics.com/press-releases/ultromics-lands-55m-series-c-to-tackle-undiagnosed-heart-failure-at-scale
- Supporting source: https://www.ultromics.com/about-ultromics
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- EchoGo AI platform analyzing standard echocardiograms to detect HFpEF, cardiac amyloidosis, and related cardiovascular conditions with FDA-cleared, Medicare-reimbursed probability scoring integrated into clinical workflows.
Extracted from the linked company product description already verified on Brel. No capabilities were invented.